Leif Glantz is Board of Directors of the company. Leif received a PhD in Nuclear Physics from Uppsala University in 1979. Between 1986 and 2007, he was CEO of the Scienta Scientific Group, a multi-national company developing high-tech research equipment in atomic and nuclear physics. Leif was Managing Director of VG Scienta AB 2008-2012 and held a managerial position in the company until 2014. From mid-2014, Leif was the majority shareholder and chairman of the board of directors of cSens AB until the company was acquired by Biovica International AB.
Haematology